Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLIT for Ragweed Allergic Rhinoconjunctivitis
NCT00599872Phase 3Completed
- Sponsor
- Greer Laboratories, Inc.
- Start
- Mar 2008
- Primary completion
- Nov 2008
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 3 trial of ambrosia artemisiifolia allergen extract in allergic rhinoconjunctivitis (ARC), sponsored by Greer Laboratories, Inc.. Started Mar 2008; status: completed.
02
Drugs
ambrosia artemisiifolia allergen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00599872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599872.